Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Equity (2016 - 2025)

Ptc Therapeutics (PTCT) has 13 years of Return on Equity data on record, last reported at 6.57% in Q4 2025.

  • For Q4 2025, Return on Equity fell 635.0% year-over-year to 6.57%; the TTM value through Dec 2025 reached 6.57%, down 635.0%, while the annual FY2025 figure was 1.91%, 166.0% down from the prior year.
  • Return on Equity reached 6.57% in Q4 2025 per PTCT's latest filing, up from 7.21% in the prior quarter.
  • Across five years, Return on Equity topped out at 11.59% in Q1 2022 and bottomed at 9.75% in Q4 2021.
  • Average Return on Equity over 5 years is 0.83%, with a median of 0.01% recorded in 2023.
  • Peak YoY movement for Return on Equity: soared 1273bps in 2022, then tumbled -1156bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 9.75% in 2021, then surged by 100bps to 0.01% in 2022, then soared by 11840bps to 0.84% in 2023, then plummeted by -126bps to 0.22% in 2024, then plummeted by -2903bps to 6.57% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 6.57% in Q4 2025, 7.21% in Q3 2025, and 6.23% in Q2 2025.